These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 9159550)
1. Case history of a patient with multiple sclerosis and scleroderma. Jawad SH; Askari A; Ward AB Br J Rheumatol; 1997 Apr; 36(4):502-3. PubMed ID: 9159550 [No Abstract] [Full Text] [Related]
3. Systemic sclerosis and multiple sclerosis. Spadaro A; Sensi F; Barrella M; Francia A J Neurol; 1999 Jun; 246(6):497-9. PubMed ID: 10431778 [No Abstract] [Full Text] [Related]
4. [Immunologic similarities observed in the course of multiple sclerosis and systemic scleroderma]. Czernicki J; Niedworok J; Onisk Z; Tchórzewski H Pol Tyg Lek; 1978 Feb; 33(9):337-40. PubMed ID: 652647 [No Abstract] [Full Text] [Related]
5. Is systemic sclerosis an antigen-driven T cell disease? Sakkas LI; Platsoucas CD Arthritis Rheum; 2004 Jun; 50(6):1721-33. PubMed ID: 15188347 [No Abstract] [Full Text] [Related]
6. [Disorders of cellular immunity in systemic scleroderma]. Sierakowski SJ; Kucharz EJ Przegl Lek; 1988; 45(7):592-7. PubMed ID: 3070641 [No Abstract] [Full Text] [Related]
7. Unusual case of progressive systemic sclerosis with onset in early childhood and following infectious mononucleosis. Urano J; Kohno H; Watanabe T Eur J Pediatr; 1981 Jul; 136(3):285-9. PubMed ID: 6973466 [TBL] [Abstract][Full Text] [Related]
10. Normal interleukin-7 (IL7) levels and normal IL7 response to CD4 T lymphopenia in patients with multiple sclerosis and systemic sclerosis. Storek J; Nash RA; McSweeney PA; Furst DE; Sullivan KM Clin Immunol; 2006 Oct; 121(1):118-9. PubMed ID: 16844418 [No Abstract] [Full Text] [Related]
12. A brief overview of the pathogenesis of scleroderma (systemic sclerosis). LeRoy EC Ann Rheum Dis; 1992 Feb; 51(2):286-8. PubMed ID: 1550420 [No Abstract] [Full Text] [Related]
13. Cellular immune dysfunction and the pathogenesis of scleroderma. Jiménez SA Semin Arthritis Rheum; 1983 Aug; 13(1 Suppl 1):104-13. PubMed ID: 6353581 [No Abstract] [Full Text] [Related]
14. [Systemic sclerosis (sclerodermia)]. Vilardell Tarrés M; Fonollosa Pla V Med Clin (Barc); 1990 May; 94(19):736-9. PubMed ID: 2201842 [No Abstract] [Full Text] [Related]
15. Development of systemic sclerosis in a patient with common variable immunodeficiency. Balci MA; Pamuk GE; Donmez S; Pamuk ON Clin Immunol; 2015 Dec; 161(2):75-6. PubMed ID: 26387631 [No Abstract] [Full Text] [Related]
16. T-cell imbalance in progressive systemic sclerosis defined by monoclonal antibodies. Claudy AL; Le Petit JC; Barthelemy H; Garcier F Arch Dermatol Res; 1982; 274(1-2):189-92. PubMed ID: 6984640 [No Abstract] [Full Text] [Related]
17. Systemic sclerosis: new insights in autoimmunity. Kaal SE; van Den Hoogen FH; de Jong EM; Viëtor HE Proc Soc Exp Biol Med; 1999 Oct; 222(1):1-8. PubMed ID: 10510242 [TBL] [Abstract][Full Text] [Related]
18. Treatment of refractory autoimmune diseases with lymphoablation and hematopoietic stem cell support. Cohen Y; Nagler A Isr Med Assoc J; 2002 Nov; 4(11 Suppl):865-7. PubMed ID: 12455162 [No Abstract] [Full Text] [Related]
19. [Etiology and pathogenesis of systemic scleroderma]. Guseva NG Revmatologiia (Mosk); 1983; (2):3-10. PubMed ID: 6312527 [No Abstract] [Full Text] [Related]
20. Treatment of cutaneous sclerosis and aplastic anemia with antithymocyte globulin. Balaban EP; Sheehan RG; Lipsky PE; Frenkel EP Ann Intern Med; 1987 Jan; 106(1):56-8. PubMed ID: 3491559 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]